Log in


  • Home
  • Statistical Considerations in the Clinical Development of Novel Cancer Therapies

Donation goal

0%
Goal:
$500.00
Collected:
$0.00

Statistical Considerations in the Clinical Development of Novel Cancer Therapies

  • Fri, December 13, 2019

Speaker: Bo Huang, PhD., Director of Biostatistics and Oncology Statistical Group Lead at Pfizer

Event info: https://www.eventbrite.com/e/statistical-considerations-in-the-clinical-development-of-novel-cancer-therapies-tickets-83105911017#

Video: https://www.youtube.com/watch?v=ER60ZwjETfU


文本转语音功能仅限200个字符
选项 : 历史 : 反馈 : Donate 关闭



@Dahshu 2020

文本转语音功能仅限200个字符
选项 : 历史 : 反馈 : Donate 关闭
G
M
T
Y
文本转语音功能仅限200个字符
Powered by Wild Apricot Membership Software